pyruvaldehyde has been researched along with Ventricular Dysfunction, Left in 1 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, NJR | 1 |
| Vulesevic, B | 1 |
| McNeill, B | 1 |
| Cimenci, CE | 1 |
| Ahmadi, A | 1 |
| Gonzalez-Gomez, M | 1 |
| Ostojic, A | 1 |
| Zhong, Z | 1 |
| Brownlee, M | 1 |
| Beisswenger, PJ | 1 |
| Milne, RW | 1 |
| Suuronen, EJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Action of Glycation and Inflammation in Operative Ischemic Heart Disease[NCT05112731] | 60 participants (Anticipated) | Observational | 2022-02-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for pyruvaldehyde and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.
Topics: Animals; Apoptosis; Cells, Cultured; Collagen Type I; Disease Models, Animal; Genetic Predisposition | 2017 |